KRYPTUS
12.5.2020 16:57:06 CEST | Business Wire | Press release
Seeking to consolidate its presence and develop new businesses in Europe, Middle East and Africa (EMEA), Brazilian Kryptus, specialized in cryptography and information security, announces the expansion of its international activities with the opening of a new unit of the company in Switzerland. The initiative is focused on offering technical support in the region, as well as develop the market, regional channel partners, and respond to local requirements. The move includes the announcement of Thierry Martin as the new director for EMEA and the head of the Swiss branch.
With a strong cybersecurity background, Martin is an engineer who has led several different technology companies in Europe and Brazil. The executive has also been a member of the Kryptus board in 2016 and 2017.
Currently providing solutions to financial institutions, private companies, and governments around the globe, Kryptus aims through this expansion to reach more customers with its competitive and unique product portfolio. The offerings include kNET, its high-performance HSM with unbreakable encryption, and Commguard, its flexible line of link encryptors.
"Kryptus can deliver world-class, trustworthy, and secure cryptography solutions for critical applications. Our presence in the region allows the optimization of services for customized or custom-developed products, providing a strong value proposition in the EMEA region," says Thierry Martin.
According to Roberto Gallo, founder & CEO of Kryptus, expanding to the EMEA region strengthens the company's position as a strategic provider of cyberdefense for governments and enterprises. "Kryptus can now extend its technology offering to Europe, Middle East, and Africa, based on relevant certifications and high performance," he points out.
With its Headquarter in Campinas, Kryptus was founded in 2003 and counts among its customers companies like BSH (a BOSCH Gmbh subsidiary), Claro Brasil (America Móvil Group), Certisign (exclusive Verisign partner in Brazil), Iron Mountain, iFood and Embraer. Granted the status of Strategic Defense Company (EED) by the Brazilian Defense Council, Kryptus has gained the trust - as a supplier from a neutral country - of several government agencies to protect their sovereignty. Among such customers with the highest security requirements, Kryptus delivered government-grade solutions to the Peruvian Navy, the Colombian Army and the Brazilian Army, Air Force, Navy, Intelligence Agency, Ministry of Foreign Affairs, and Superior Electoral Court, as well as to several other governments.
About Thierry Martin
Thierry Martin was born in Switzerland where he studied Electronics and Computer Science. He has professional experience in various areas of technology, among them Digital TV, Cyber Security, Electronics, and Telecommunications. Along his career he has lived and worked in Switzerland, Spain, the United Kingdom, and Brazil, as well as worked extensively with the United States and Asia. He has held executive positions in companies like Nagra, Kudelski Security, Selectron Systems AG, and Mouvent AG.
About Kryptus
Kryptus is a provider of solutions in Information Security. With 17 years of history and HQ in Campinas (SP), Kryptus SA is an independent Brazilian company that has been growing consistently for the past 10 years, focusing on long term actions, scientific and technological plans, and understanding the mission of its clients in the business lines it develops. Kryptus is a partner of the Kudelski Group. Kryptus is a Brazilian Strategic Defense Company (EED), a status granted by the Brazilian Defense Council.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005624/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
TOHKnet and Adtran conduct Japan’s first 50G PON trial on a live network4.8.2026 09:00:00 CEST | Press release
News summary: TOHKnet is exploring next-generation PON to meet enterprise demand while maintaining continuity across its regional fiber network Using Adtran technology, the trial validated 50G PON, XGS-PON and EPON operating together on a single fiber network Results show a practical path to evolve networks, enabling phased upgrades while maximizing fiber assets and avoiding service disruption Adtran today announced that TOHKnet has completed Japan’s first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran’s SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existing services, maximizing the value of deployed fiber assets and reducing the complexity and disruption typically associated with network
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom